PATHWAY REHABILITATION HOSPITAL LLC
1. Target Overview & Investment Thesis
PATHWAY REHABILITATION HOSPITAL LLC is a 15-bed community hospital in nan, LA with $5.7M in net patient revenue and a -7.4% operating margin. The hospital serves a payer mix of 86.2% Medicare, 0.0% Medicaid, and 13.8% commercial.
Thesis: Turnaround. Our ML models identify $432K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -7.4% to 0.1% (+755bps).
| Net Revenue HCRIS | $5.7M |
| Current EBITDA COMPUTED | $-425K |
| Operating Margin COMPUTED | -7.4% |
| Occupancy HCRIS | 46.4% |
| Revenue / Bed COMPUTED | $381K |
| Net-to-Gross HCRIS | 58.1% |
| Distress Probability ML | nan% |
2. Market Context & Competitive Position
LA has 212 Medicare-certified hospitals with a median operating margin of -3.5%. The target's margin of -7.4% places it below the state median. Among 88 size-comparable peers (8-30 beds), the median margin is -1.5%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (8-30), prioritizing same-state peers. 88 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| PATHWAY REHABILITATION HOSPITA (Target) | LA | 15 | $5.7M | -7.4% |
| SPECIALISTS HOSPITAL OF SHREVE | LA | 15 | $79.1M | 21.3% |
| OCHSNER BAYOU LLC | LA | 25 | $76.5M | -0.9% |
| CENTRAL LOUISIANA SURGICAL HOS | LA | 24 | $69.1M | 7.7% |
| ST. CHARLES PARISH HOSPITAL | LA | 27 | $64.0M | -5.1% |
| AVALA | LA | 21 | $64.0M | 7.4% |
| THE SPINE HOSPITAL OF LOUISIAN | LA | 23 | $57.4M | 35.4% |
| PARK PLACE SURGERY CENTER | LA | 10 | $51.6M | 15.4% |
| SURGICAL SPECIALTY CENTER BATO | LA | 16 | $49.8M | 16.9% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $432K (755bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $120K | +210bp | 18mo |
| Denial Rate Reduction | 12.0% | 6.5% | $118K | +207bp | 12mo |
| Cost to Collect | 4.5% | 2.5% | $114K | +200bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $70K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $10K | +17bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-425K |
| + RCM Uplift | +$432K |
| Pro Forma EBITDA | $7K |
| Current Margin | -7.4% |
| Pro Forma Margin | 0.1% |
| WC Released (1x) | $219K |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-654K | $1.5M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-654K | $1.5M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-588K | $2.7M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-588K | $2.7M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-719K | $-431K | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-719K | $-708K | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Heavy Medicare dependence | Medicare comprises 86.2% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 88 hospitals with 8-30 beds
- Same-state prioritization (n=90)
- Comp margins: P25=-14.3% / P50=-1.5% / P75=8.7%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.